Chinese healthcare-focused venture capital and private equity firm HighLight Capital has reached the close of its second US dollar-denominated fund at the hard cap of $250 million, as per a report in AVCJ.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
